Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT07444320
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT07444320
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Croatia, Czechia, Hong Kong SAR China, Taiwan
- Registry status
- Recruiting
Technical summary
Registry record NCT07444320. Allocation not applicable; no masking; primary purpose treatment. Start 2026-02-12 (actual); primary completion 2028-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
- Acronym
- IMPULSE-EVO
- Condition
- Paroxysmal Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- FARAPULSE™ Pulsed Field Ablation (PFA) System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct07444320- Content hash
57a79cd4e94fc03d4dcd4e603e01b724d16aa5cd1f82a8edd684f941a052f095